News from amri A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

09 May, 2018, 13:00 BST AMRI Celebrates Grand Opening of New State-of-the-Art Aseptic API Line in Valladolid, Spain

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and...


22 Feb, 2018, 12:00 GMT AMRI to Expand Container Closure Integrity Testing Services (CCIT) into European Union

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and...


21 Feb, 2018, 12:30 GMT AMRI Appoints Anthony L. Mattacchione to Senior Vice President and Chief Financial Officer

AMRI, a global pharmaceutical contract research, development and manufacturing organization, today announced the appointment of Anthony ('Tony')...


04 Jan, 2018, 19:00 GMT AMRI Names Michael Mulhern as Chief Executive Officer

AMRI, a global pharmaceutical contract research, development and manufacturing organization, today announced that Michael Mulhern has joined the...


30 Nov, 2017, 13:00 GMT AMRI Doubles Bulk API Aseptic Manufacturing Capacity

AMRI, a global contract research, development and manufacturing organization, has more than doubled its current bulk Active Pharmaceutical Ingredient ...


23 Oct, 2017, 13:00 BST AMRI to Highlight Sterile Manufacturing Capacity Expansion, New Technologies at CPhI

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and...


06 Jun, 2017, 12:30 BST AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash

Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences...


09 May, 2017, 12:30 BST AMRI Announces First Quarter 2017 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2017 and provided an update to its outlook...


21 Feb, 2017, 13:05 GMT AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products

AMRI (NASDAQ: AMRI) today announced that it has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare, Inc. ("Accord...


21 Feb, 2017, 12:28 GMT AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook

AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2016 and provided an...


03 Oct, 2016, 14:47 BST AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona

AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be showcasing its comprehensive portfolio of active...


11 Jul, 2016, 12:25 BST AMRI Completes Acquisition of Euticals

AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Prime European Therapeuticals S.p.A., also known as "Euticals", a...


22 Jun, 2016, 13:00 BST Teewinot Life Sciences Corporation Licenses Biosynthetic Technology to AMRI for the Production and Sale of the First Commercially Available CBCA Analytical Standard

Teewinot Life Sciences Corporation (Teewinot) and Albany Molecular Research, Inc. (NASDAQ: AMRI) today announced that AMRI has licensed Teewinot's...


05 May, 2016, 12:49 BST AMRI to Acquire Euticals in a Strategic Transaction That Expands its API Development and Manufacturing Business

Enters definitive agreement to acquire Euticals for $358 million in stock, cash and a seller note Positions AMRI as one of the largest independent...


15 Dec, 2015, 13:17 GMT AMRI Acquires Whitehouse Laboratories

AMRI (NASDAQ: AMRI) today announced that it has acquired all the outstanding equity interests of Whitehouse Laboratories, a leading provider of...


13 Nov, 2015, 13:00 GMT AMRI CEO to Present at Jefferies Autumn 2015 Global Healthcare Conference London

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


05 Nov, 2015, 12:00 GMT AMRI Announces Third Quarter 2015 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30 2015. Highlights: Third quarter contract...


31 Aug, 2015, 12:00 BST AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients

AMRI (NASDAQ: AMRI) and Saneca Pharmaceuticals, a.s. today announced a strategic collaboration focused on the development, manufacture and marketing...


04 Aug, 2015, 12:30 BST AMRI Announces Second Quarter 2015 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2015. Highlights: Second quarter contract...


16 Jul, 2015, 12:30 BST AMRI Acquires Gadea Pharmaceutical Group

AMRI (NASDAQ: AMRI) today announced that it has acquired all the outstanding shares of Gadea Pharmaceutical Group, a privately-held company located...


17 Jun, 2015, 12:00 BST AMRI and PerkinElmer Announce Drug Discovery Collaboration as part of the Buffalo Medical Innovation and Commercialization Hub

As further evidence of Governor Andrew M. Cuomo's successful establishment of a dynamic and growing bio-pharma sector in Buffalo, New York, Albany...


01 Jun, 2015, 12:00 BST AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y.

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaborative agreement with biotechnology company HarkerBIO LLC...


05 May, 2015, 12:30 BST AMRI Announces First Quarter 2015 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2015. Highlights: First quarter contract...


01 May, 2015, 13:00 BST AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at...


02 Apr, 2015, 21:14 BST AMRI to Close Holywell, U.K. API Manufacturing Facility

AMRI (NASDAQ: AMRI) announced today that it has decided to close its Holywell, U.K. facility following a consultation process with employee...